IRIS Accounts Production v26.1.10.61 12535808 Board of Directors 1.9.24 31.8.25 31.8.25 Medium entities true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125358082024-08-31125358082025-08-31125358082024-09-012025-08-31125358082023-08-31125358082023-09-012024-08-31125358082024-08-3112535808ns15:EnglandWales2024-09-012025-08-3112535808ns14:PoundSterling2024-09-012025-08-3112535808ns10:Director12024-09-012025-08-3112535808ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3112535808ns10:MediumEntities2024-09-012025-08-3112535808ns10:Audited2024-09-012025-08-3112535808ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-09-012025-08-3112535808ns10:Medium-sizedCompaniesRegimeForAccounts2024-09-012025-08-3112535808ns10:FullAccounts2024-09-012025-08-3112535808ns10:OrdinaryShareClass12024-09-012025-08-3112535808ns10:Director22024-09-012025-08-3112535808ns10:Director32024-09-012025-08-3112535808ns10:Director42024-09-012025-08-3112535808ns10:RegisteredOffice2024-09-012025-08-3112535808ns10:Director52024-09-012025-08-3112535808ns5:ContinuingOperations2024-09-012025-08-3112535808ns5:DiscontinuedOperations2024-09-012025-08-3112535808ns5:ContinuingOperations2023-09-012024-08-3112535808ns5:DiscontinuedOperations2023-09-012024-08-3112535808ns5:CurrentFinancialInstruments2025-08-3112535808ns5:CurrentFinancialInstruments2024-08-3112535808ns5:ShareCapital2025-08-3112535808ns5:ShareCapital2024-08-3112535808ns5:RetainedEarningsAccumulatedLosses2025-08-3112535808ns5:RetainedEarningsAccumulatedLosses2024-08-3112535808ns5:ShareCapital2023-08-3112535808ns5:RetainedEarningsAccumulatedLosses2023-08-3112535808ns5:RetainedEarningsAccumulatedLosses2023-09-012024-08-3112535808ns5:RetainedEarningsAccumulatedLosses2024-09-012025-08-311253580812024-09-012025-08-3112535808ns5:ReportableOperatingSegment12024-09-012025-08-3112535808ns5:ReportableOperatingSegment12023-09-012024-08-3112535808ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2024-09-012025-08-3112535808ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-09-012024-08-3112535808ns15:UnitedKingdom2024-09-012025-08-3112535808ns15:UnitedKingdom2023-09-012024-08-3112535808ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-09-012025-08-3112535808ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-09-012024-08-3112535808ns5:OwnedAssets2024-09-012025-08-3112535808ns5:OwnedAssets2023-09-012024-08-3112535808ns5:ComputerEquipment2024-08-3112535808ns5:ComputerEquipment2024-09-012025-08-3112535808ns5:ComputerEquipment2025-08-3112535808ns5:ComputerEquipment2024-08-3112535808ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3112535808ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3112535808ns10:OrdinaryShareClass12025-08-3112535808ns5:RetainedEarningsAccumulatedLosses2024-08-3112535808ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-09-012025-08-311253580812024-09-012025-08-31
REGISTERED NUMBER: 12535808 (England and Wales)









Skin + Me Ltd

Strategic Report, Report of the Directors and

Financial Statements

for the Year Ended 31 August 2025






Skin + Me Ltd (Registered number: 12535808)






Contents of the Financial Statements
for the Year Ended 31 August 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 9

Other Comprehensive Income 11

Balance Sheet 12

Statement of Changes in Equity 13

Cash Flow Statement 14

Notes to the Cash Flow Statement 15

Notes to the Financial Statements 16


Skin + Me Ltd

Company Information
for the Year Ended 31 August 2025







DIRECTORS: G J Bosher
H H H Cary
W J Gibbs
J A Mishreki





REGISTERED OFFICE: 2 Eastbourne Terrace Floor 4
London
W2 6LG





REGISTERED NUMBER: 12535808 (England and Wales)





AUDITORS: UHY Hacker Young (Birmingham) LLP,
Statutory Auditor
9-11 Vittoria Street
Birmingham
B1 3ND

Skin + Me Ltd (Registered number: 12535808)

Strategic Report
for the Year Ended 31 August 2025

The directors are happy to report on continued growth during the period. The company operates only in the UK, and as a subscription business benefits from predictable revenue from repeating customers. Continual investment in infrastructure and good relationships with suppliers allow the company to scale while maintaining our strong gross margins.

BUSINESS REVIEW
The company has reported a turnover of £10,538,495 (2024: £10,047,549) and a pre-tax profit of £3,354,060 (2024: £4,760,346) for the year. The company has total shareholder's funds of £9,940,089 as at 31 August 2025 (2024:£6,582,945)
- Turnover increased from 2024 by £490,946 (5%).
- Pre-tax profit decreased from 2024 by £1,406,286 (30%).
- Cash held at year end is £2,538,946 down from £6,577,641 in 2024.

PRINCIPAL RISKS AND UNCERTAINTIES
The risk areas that have been identified by the directors are as follows:

Recruitment of enough qualified, specialist staff for continued business growth.

FINANCIAL KEY PERFORMANCE INDICATORS
31/08/2025 31/08/2024
£    £   
Turnover 10,538,495 10,047,549
Gross profit margin % 83% 84%


ON BEHALF OF THE BOARD:





H H H Cary - Director


22 May 2026

Skin + Me Ltd (Registered number: 12535808)

Report of the Directors
for the Year Ended 31 August 2025

The directors present their report with the financial statements of the company for the year ended 31 August 2025.

PRINCIPAL ACTIVITY
The principal activity of the company is that of prescribing services and the provision of cosmetic skincare products.

DIVIDENDS
No dividends will be distributed for the year ended 31 August 2025.

EVENTS SINCE THE END OF THE YEAR
Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 September 2024 to the date of this report.

G J Bosher
H H H Cary
W J Gibbs
J A Mishreki

Other changes in directors holding office are as follows:

A Szirtes - resigned 25 March 2025

DIRECTORS' INDEMNITY INSURANCE
Directors' liability and indemnity insurance was in force throughout the period to cover the directors and officers of the company against actions brought against them in their personal capacity. Neither the insurance nor the indemnity provide cover where the individual has acted fraudulently or dishonestly.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.


Skin + Me Ltd (Registered number: 12535808)

Report of the Directors
for the Year Ended 31 August 2025

STATEMENT OF DIRECTORS' RESPONSIBILITIES - continued
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, UHY Hacker Young (Birmingham) LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





H H H Cary - Director


22 May 2026

Report of the Independent Auditors to the Members of
Skin + Me Ltd

Opinion
We have audited the financial statements of Skin + Me Ltd (the 'company') for the year ended 31 August 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 August 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Report of the Independent Auditors to the Members of
Skin + Me Ltd


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on pages three and four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Skin + Me Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- Identify and assess the risks of material misstatement of the financial statements, whether due to fraud
or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is
sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material
misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations or the override of internal control.

- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness
of the internal control.

- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates
and related disclosures made by the directors.

- Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based
on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that
may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a
material uncertainty exists, we are required to draw attention in our auditor's report to the related
disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our
conclusions are based on the audit evidence obtained up to the date of our auditor's report. However,
future events or conditions may cause the company to cease to continue as a going concern.

- Evaluate the overall presentation, structure and content of the financial statements, including the
disclosures, and whether the financial statements represent the underlying transactions and events in a
manner that achieves fair presentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Skin + Me Ltd


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Aaron Thomas , Senior Statutory Auditor
for and on behalf of UHY Hacker Young (Birmingham) LLP,
Statutory Auditor
9-11 Vittoria Street
Birmingham
B1 3ND

22 May 2026

Skin + Me Ltd (Registered number: 12535808)

Income Statement
for the Year Ended 31 August 2025

2025 2025 2025
Continuing Discontinued Total
Notes £    £    £   

TURNOVER 3 9,450,111 1,088,384 10,538,495
Cost of sales (1,350,972 ) (398,869 ) (1,749,841 )
GROSS PROFIT 8,099,139 689,515 8,788,654

Administrative expenses (4,523,138 ) (951,247 ) (5,474,385 )

OPERATING PROFIT/(LOSS) 5 3,576,001 (261,732 ) 3,314,269

Interest receivable and similar income 39,791 - 39,791
PROFIT/(LOSS) BEFORE TAXATION 3,615,792 (261,732 ) 3,354,060
Tax on profit/(loss) 6 - - -
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

3,615,792

(261,732

)

3,354,060

Skin + Me Ltd (Registered number: 12535808)

Income Statement
for the Year Ended 31 August 2025

2024 2024 2024
Continuing Discontinued Total
Notes £    £    £   

TURNOVER 3 10,024,494 23,055 10,047,549
Cost of sales (1,546,672 ) (27,789 ) (1,574,461 )
GROSS PROFIT/(LOSS) 8,477,822 (4,734 ) 8,473,088

Administrative expenses (3,664,922 ) (251,700 ) (3,916,622 )

OPERATING PROFIT/(LOSS) 5 4,812,900 (256,434 ) 4,556,466

Interest receivable and similar income 203,880 - 203,880
PROFIT/(LOSS) BEFORE TAXATION 5,016,780 (256,434 ) 4,760,346
Tax on profit/(loss) 6 - - -
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

5,016,780

(256,434

)

4,760,346

Skin + Me Ltd (Registered number: 12535808)

Other Comprehensive Income
for the Year Ended 31 August 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 3,354,060 4,760,346


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR
THE YEAR

3,354,060

4,760,346

Skin + Me Ltd (Registered number: 12535808)

Balance Sheet
31 August 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 1,208 2,684

CURRENT ASSETS
Debtors 8 73,236,124 43,574,262
Cash at bank 2,538,946 6,577,641
75,775,070 50,151,903
CREDITORS
Amounts falling due within one year 9 65,836,189 43,571,642
NET CURRENT ASSETS 9,938,881 6,580,261
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,940,089

6,582,945

CAPITAL AND RESERVES
Called up share capital 10 1 1
Retained earnings 11 9,940,088 6,582,944
SHAREHOLDERS' FUNDS 9,940,089 6,582,945

The financial statements were approved by the Board of Directors and authorised for issue on 22 May 2026 and were signed on its behalf by:





H H H Cary - Director


Skin + Me Ltd (Registered number: 12535808)

Statement of Changes in Equity
for the Year Ended 31 August 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 September 2023 1 1,819,373 1,819,374

Changes in equity
Total comprehensive income - 4,760,346 4,760,346
Share based payment option - 3,225 3,225
Balance at 31 August 2024 1 6,582,944 6,582,945

Changes in equity
Total comprehensive income - 3,354,060 3,354,060
Share based payment option - 3,084 3,084
Balance at 31 August 2025 1 9,940,088 9,940,089

Skin + Me Ltd (Registered number: 12535808)

Cash Flow Statement
for the Year Ended 31 August 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 (4,078,486 ) 798,619
Net cash from operating activities (4,078,486 ) 798,619

Cash flows from investing activities
Interest received 39,791 203,880
Net cash from investing activities 39,791 203,880

(Decrease)/increase in cash and cash equivalents (4,038,695 ) 1,002,499
Cash and cash equivalents at beginning
of year

2

6,577,641

5,575,142

Cash and cash equivalents at end of
year

2

2,538,946

6,577,641

Skin + Me Ltd (Registered number: 12535808)

Notes to the Cash Flow Statement
for the Year Ended 31 August 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Profit before taxation 3,354,060 4,760,346
Depreciation charges 1,476 1,801
Increase in amounts to group companies (8,269,916 ) (2,987,799 )
Share based payment option 3,084 3,225
Finance income (39,791 ) (203,880 )
(4,951,087 ) 1,573,693
Decrease/(increase) in trade and other debtors 766,849 (830,121 )
Increase in trade and other creditors 105,752 55,047
Cash generated from operations (4,078,486 ) 798,619

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 August 2025
31.8.25 1.9.24
£    £   
Cash and cash equivalents 2,538,946 6,577,641
Year ended 31 August 2024
31.8.24 1.9.23
£    £   
Cash and cash equivalents 6,577,641 5,575,142


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.9.24 Cash flow At 31.8.25
£    £    £   
Net cash
Cash at bank and in hand 6,577,641 (4,038,695 ) 2,538,946
6,577,641 (4,038,695 ) 2,538,946
Total 6,577,641 (4,038,695 ) 2,538,946

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements
for the Year Ended 31 August 2025

1. STATUTORY INFORMATION

Skin + Me Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

Financial Reporting Standard 102 - reduced disclosure exemptions
The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

• the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45,
11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
• the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27,
12.29(a), 12.29(b) and 12.29A;
• the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Mr & Mrs Oliver Ltd as at 31 August 2025 and these financial statements may be obtained from 2 Eastbourne Terrace Floor 4, London, England, W2 6LG.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued

Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods
Revenue from the sale of goods is recognised when all of the following conditions are satisfied:

• the Company has transferred the significant risks and rewards of ownership to the buyer;
• the Company retains neither continuing managerial involvement to the degree usually
associated with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the Company will receive the consideration due under the transaction; and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

• the amount of revenue can be measured reliably;
• it is probable that the Company will receive the consideration due under the contract;
• the stage of completion of the contract at the end of the reporting period can be measured
reliably; and
• the costs incurred and the costs to complete the contract can be measured reliably.

Interest income
Interest income is recognised in profit or loss using the effective interest method.

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment - 33% on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The Company has elected to apply the provisions of Section 11 "Basic Financial Instruments" of
FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets
Financial assets are assessed for indicators of impairment at each reporting date.
Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.


Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued
Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments
Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

Derecognition of financial instruments

Derecognition of financial assets
Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives, which range from 3 to 6 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Foreign currency translation
Functional and presentation currency
The Company's functional and presentational currency is GBP.

Transactions and balances
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non­ monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
Defined contribution pension plan
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Share-based payments
Where share options are awarded to employees, the fair value of the options at the date of grant is charged to profit or loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each balance sheet date so that, ultimately, the cumulative amount recognised over the vesting period is based on the number of options that eventually vest. Market vesting conditions are factored into the fair value of the options granted. The cumulative expense is not adjusted for failure to achieve a market vesting condition.

The fair value of the award also takes into account non-vesting conditions. These are either factors beyond the control of either party (such as a target based on an index) or factors which are within the control of one or other of the parties (such as the Group keeping the scheme open or the employee maintaining any contributions required by the scheme).

Where the terms and conditions of options are modified before they vest, the increase in the fair value of the options, measured immediately before and after the modification, is also charged to profit or loss over the remaining vesting period.

Where equity instruments are granted to persons other than employees, profit or loss is charged with fair value of goods and services received.

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2025 2024
£    £   
Product and cosmetic sales 10,538,495 10,047,549
10,538,495 10,047,549

An analysis of turnover by geographical market is given below:

2025 2024
£    £   
United Kingdom 10,538,495 10,047,549
10,538,495 10,047,549

4. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 1,772,403 1,458,848
Social security costs 204,558 155,515
Other pension costs 35,174 31,760
2,012,135 1,646,123

The average number of employees during the year was as follows:
2025 2024

Employees 48 37

No directors received remuneration from the company in the year (2024: nil). No directors were accruing pension benefits in respect of the defined contribution pension scheme in the year (2024: nil).

2025 2024
£    £   
Directors' remuneration - -

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2025 2024
£    £   
Depreciation - owned assets 1,476 1,801
Auditors' remuneration 8,300 8,000
Auditors' remuneration for non audit work 1,100 1,000
Foreign exchange differences 308 (58 )

6. TAXATION

Analysis of the tax charge
No liability to UK corporation tax arose for the year ended 31 August 2025 nor for the year ended 31 August 2024.

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 3,354,060 4,760,346
Profit multiplied by the standard rate of corporation tax in the UK
of 25% (2024 - 25%)

838,515

1,190,087

Effects of:
Expenses not deductible for tax purposes 1,465 1,998
Depreciation in excess of capital allowances 369 450
Share option exercise (6,948 ) (658 )
Group relieved (833,401 ) (1,191,877 )
Total tax charge - -

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

7. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 September 2024
and 31 August 2025 4,485
DEPRECIATION
At 1 September 2024 1,801
Charge for year 1,476
At 31 August 2025 3,277
NET BOOK VALUE
At 31 August 2025 1,208
At 31 August 2024 2,684

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 171,868 -
Amounts owed by group undertakings 71,945,124 41,516,413
Other debtors 998,803 959,719
VAT 120,329 1,090,476
Prepayments - 7,654
73,236,124 43,574,262

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 23,633 4,866
Amounts owed to group undertakings 65,510,805 43,352,010
Social security and other taxes 45,914 44,553
Other creditors 6,930 6,841
Accruals and deferred income 248,907 163,372
65,836,189 43,571,642

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
1 Ordinary 1 1 1

11. RESERVES
Retained
earnings
£   

At 1 September 2024 6,582,944
Profit for the year 3,354,060
Share based payment option 3,084
At 31 August 2025 9,940,088

12. PENSION COMMITMENTS

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £35,174 (2024: £31,760). Contributions totalling £6,918 (2024: £6,841) were payable to the fund at the balance sheet date and are included in creditors.

13. RELATED PARTY TRANSACTIONS

Entities with control, joint control or significant influence over the entity

The company has taken advantage of the exemption available in Financial Reporting Standard 102 Section 33 whereby it has not disclosed transactions with the ultimate parent company or any wholly owned subsidiary undertaking of the group. The consolidated financial statements of the ultimate parent company, Mr & Mrs Oliver Ltd are available from Registrar of Companies, Companies House, Cardiff, CF14 3UZ.

14. POST BALANCE SHEET EVENTS

The group have recently decided to discontinue two of their business units. AndBegin was stopped as hyper personalisation was found to not be a key requirement from customers. Retail was stopped as, although it provided an opportunity to target currently unserved customers, following the success of the + Me brand, the business has the opportunity to invest more into the other high performing business units.

15. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party

Skin + Me Ltd (Registered number: 12535808)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

16. SHARE-BASED PAYMENT TRANSACTIONS

The company operates an equity settled share-based payment scheme for directors, employees and select consultants.

Share-based payments are calculated in accordance with FRS 102 section 26. The company uses the Guideline Public Company method to value the options.

The fair value determined is expensed on a straight-line basis over the requisite service period for each separately vesting portion. The charge for the period is allocated to the relevant income statement categories where the employment costs of the employee who is granted the equity options are charged.

31 August31 August31 August31 August
2025202520242024
WeightedWeighted
AverageAverage
ExerciseExercise
Price (pence)NumberPrice (pence)Number

Enterprise Management Scheme36.636,77727.772,463




31 August31 August
20252024
NumberNumber
Brought forward72,46377,600
Granted in the period2,7994,544
Exercised in the period(27,340)(2,739)
Forfeited in the period(11,145)(6,942)
Carried forward36,77772,463
Exercisable quantity (vested)49,20441,587

The total charge for the year recognised as administrative expenses was £3,084 (2024: £3,225).

17. CONTROLLING PARTY

The company's parent company is Mr & Mrs Oliver Ltd, a company incorporated in England and Wales.